Substances for the treatment and prophylaxis of macular degeneration
Age-related macular degeneration (AMD) is differentiated into a ?dry? and a ?wet? form of progression. With approx. 85 % of cases, dry AMD occurs far more often. With this form of the disease, over a period of several years, loss of light-sensitive cells in the retina occurs. One cause, amongst others, is the accumulation of a retinoid component, A2E (N-retinyl-N-retinylidene ethanolamine) in the macular region, above all in RPE cells (retinal pigment epithelial cells). That A2E induces apoptosis in RPE cells is known.<br><br>
In this context, new substances are introduced which bind A2E (N-retinyl-N-retinylidene ethanolamine) and prevent the apoptosis induced by A2E in RPE cells (retinal pigment epithelial cells). These new substances are suitable for the (acute) treatment and prophylaxis of patients with dry AMD, whereby the success of the treatment can be determined easily by a decrease of lipofuscin fluorescence in the macula.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Combining robotics and ChatGPT
TUM professor uses ChatGPT for choreographies with flying robots. Prof. Angela Schoellig has proved that large language models can be used safely in robotics. ChatGPT develops choreographies for up to…
How the Immune System Learns from Harmless Particles
Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…
Biomarkers identified for successful treatment of bone marrow tumours
CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…
